Welcome!

AJAX & REA Authors: Piram Manickam, Subrahmanya SV, S Sangeetha, Bob Gourley, RealWire News Distribution

News Feed Item

Echo Therapeutics to Present at the Noble Financial Capital Markets' Ninth Annual Equity Conference

PHILADELPHIA, Jan. 15, 2013 /PRNewswire/ -- Echo Therapeutics, Inc. (NASDAQ: ECTE), a company developing its needle-free Symphony® tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system, today announced that Patrick T. Mooney, M.D., Chairman and CEO of Echo Therapeutics will present at "NINE", Noble Financial Capital Markets' Ninth Annual Equity Conference.

(Logo: http://photos.prnewswire.com/prnh/20120801/NE50071LOGO)

Dr. Mooney will make a corporate presentation to prospective corporate partners and investors at 10:00 AM EST on Tuesday, January 22nd.  The Company's presentation will be delivered at the Hard Rock Hotel in Hollywood, Florida.

At the time of the presentation, a live audio and high-definition video webcast of Dr. Mooney's presentation and a copy of the presentation materials will be available in the Events section of the company's website at www.echotx.com, or through the Noble Financial websites: www.noblefcm.com or www.nobleresearch.com/NINE/home.htm.  Echo recommends registering at least 10 minutes prior to the start of the presentation to ensure timely access.  You will require a Microsoft SilverLight viewer (a free download from the presentation link) to participate.  The webcast and presentation will also be archived on www.echotx.com for 90 days following the event. 

About Echo Therapeutics

Echo Therapeutics is developing the Symphony tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system.  Our target is patients who could benefit from glucose monitoring in the hospital setting, including critical care.  Significant opportunity also exists for patients with diabetes to use Symphony in the outpatient setting.  Echo is also developing its needle-free skin preparation component of Symphony, the Prelude® SkinPrep System, as a platform technology to enhance drug delivery of topical pharmaceuticals.

Cautionary Statement Regarding Forward Looking Statements

The statements in this press release that are not historical facts may constitute forward-looking statements that are based on current expectations and are subject to risks and uncertainties that could cause actual future results to differ materially from those expressed or implied by such statements. Those risks and uncertainties include, but are not limited to, risks related to regulatory approvals and the success of Echo's ongoing studies, including the safety and efficacy of Echo's Symphony tCGM System, the failure of future development and preliminary marketing efforts related to Echo's Symphony tCGM and Prelude SkinPrep Systems, Echo's ability to secure additional commercial partnering arrangements, risks and uncertainties relating to Echo's and its partners' ability to develop, market and sell diagnostic and transdermal drug delivery products based on its skin permeation platform technologies, including the Symphony tCGM and Prelude SkinPrep Systems, the availability of substantial additional equity or debt capital to support its research, development and product commercialization activities, and the success of its research, development, regulatory approval, marketing and distribution plans and strategies, including those plans and strategies related to its Symphony tCGM and Prelude SkinPrep Systems. These and other risks and uncertainties are identified and described in more detail in Echo's filings with the Securities and Exchange Commission, including, without limitation, its Annual Report on Form 10-K for the year ended December 31, 2011, its Quarterly Reports on Form 10-Q, and its Current Reports on Form 8-K. Echo undertakes no obligation to publicly update or revise any forward-looking statements.

For More Information:
Christine H. Olimpio
Director, Investor Relations and Corporate Communications
(215) 717-4104
colimpio@echotx.com

Connect With Us:
- Visit our website at www.echotx.com
- Follow us on Twitter at www.twitter.com/echotx
- Join us on Facebook at www.facebook.com/echotx

SOURCE Echo Therapeutics, Inc.

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Cloud Expo Breaking News
In an ideal developer/systems administrator’s world, most applications would deploy seamlessly to multiple platforms and scale elastically with minimal effort bringing the unprecedented agility of the cloud within immediate reach of developer teams and IT organizations. OpenStack, a RackSpace and NASA initiative, is now managed by an independent foundation and is supported by multiple vendors. It defines APIs for compute, storage, networking, services, monitoring, and additional infrastructure...
Companies around the world are moving into on-premise private cloud environments. Many connect their private cloud to their public cloud service providers. In his session at 12th Cloud Expo | Cloud Expo New York [June 10-13], Brian Patrick Donaghy will talk about examples of what worked, what failed and why we should think about this evolution.
Enterprise cloud adoption revolves around pushing the BYOD movement and focusing on data security. In his session at the 12th International Cloud Expo, Ross Brouse, COO and President of Solar VPS, will cover how cloud adoption is driven by consumerism, humanity’s need to socialize, our addiction to new gadgets and the ability of data to stay secure in a growing collaborative world. The cloud is a drug and we’re just getting hooked. Ross Brouse is the COO and President of Solar VPS. He is a tr...
Organizations across the world are increasingly starting to see the benefits of moving more and more services to the cloud. The focus on the cost-saving potential of cloud is rapidly shifting to completely transforming the business with cloud. As organizations are investing enormous sums on technology they are starting to realize that in order to maximize the return on investment and accelerate the business transformation process the first area of focus should be people. By ensuring the organiza...
A recent study by analyst firm IDC reports that in 2012, 1.7 million cloud computing-related roles across the globe could not be filled due to the lack of training, certification and experience in the applicant pool. As the global demand for cloud and big data expertise increases, employers are finding it difficult to recruit talent, which is slowing down the ability for organizations to adopt, implement, and realize benefits from innovative platforms like OpenStack. In this session join Clo...
Our more interconnected planet is accelerating the adoption and convergence of next-generation architectures, in the form of cloud, mobile and instrumented physical assets. Organizations that can effectively balance optimization and innovation, will be in a position to leverage new systems of engagement, out maneuver their peers and achieve desired outcomes. In the Opening Keynote at 12th Cloud Expo | Cloud Expo New York, IBM GM & Next Generation Platform CTO Dr Danny Sabbah will detail the crit...
The cloud-enabled data center sits at the center of IT transformation. It facilitates the interconnection and communities that come together, propelling growth for both buyers and sellers. In his session at the 12th International Cloud Expo, Gerry Fassig, CoreSite’s Vice President of Sales, will discuss how CoreSite is bringing together best-of-breed partners through the Open Cloud Exchange resulting in public, private, and hybrid cloud interconnection and management as well as connectivity to...
Companies around the world are collecting massive amounts of data everyday that’s sitting around and not being utilized. Take for example the fact that companies collect demographic and location-based data via mobile devices all the time, but have to figure out how to monetize that data. In this session, Joyent CTO and founder Jason Hoffman will examine the state of Big Data, taking a look at what we're doing now to discussing what's on the horizon, as companies prepare and realign their busines...
Enterprises can't close their doors just because integration tools won't cope with the volume of information that their systems produce. As each day goes by, their information will become larger and more complicated, and enterprises must constantly struggle to manage the integration of dozens (or hundreds) of systems. Apache Hadoop has quickly become the technology of choice for enterprises that need to perform complex analysis of petabytes of data, but few are aware of its potential to hand...
Planning scalable environments isn't terribly difficult, but it does require a change of perspective. During this session we'll broaden our views to think on an Internet Scale by dissecting a video publishing application built with The SoftLayer Platform, Message Queuing, Object Storage, and Drupal. By examining a scalable modular application build that can handle unpredictable traffic, you'll be able to grow your development arsenal and pick up a few strategies to apply to your own projects.